Patents by Inventor Damir Vidovi?

Damir Vidovi? has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7560104
    Abstract: Compositions and methods for eliciting an in vivo cytotoxic lymphocyte (CTL) response against a modified soluble protein antigen are disclosed. The modified soluble protein antigen comprises an added peptidic sequence which facilitates entry of the modified antigen into antigen presenting cells (APC).
    Type: Grant
    Filed: June 16, 2006
    Date of Patent: July 14, 2009
    Assignee: Dendreon Corporation
    Inventors: Reiner Laus, Itzhak Hakim, Damir Vidović
  • Patent number: 7148324
    Abstract: Compositions and methods for eliciting an in vivo cytotoxic lymphocyte (CTL) response against a modified soluble protein antigen are disclosed. The modified soluble protein antigen comprises an added peptidic sequence which facilitates entry of the modified antigen into antigen presenting cells (APC).
    Type: Grant
    Filed: December 14, 1999
    Date of Patent: December 12, 2006
    Assignee: Dendreon Corporation
    Inventors: Reiner Laus, Itzhak Hakim, Damir Vidović